Shortify
More news in less time
Home
/
Topic
#
gb268
1 story
Follow
#
colorectal cancer
#
eddingpharm
#
finance
#
immunotherapy
#
markets
#
nmpa
#
phase 2 trial
#
pmmr/mss
Eddingpharm's GB268 Trial Approved in China
China's NMPA clears Eddingpharm's GB268 Phase 2 colorectal cancer trial.
BigGo Finance · 1m
Load more stories
